Individual Patient Exposure and Response in Pediatric Lupus

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

June 16, 2021

Study Completion Date

June 16, 2021

Conditions
Systemic Lupus Erythematosus
Interventions
BEHAVIORAL

Pillsy

"The electronic pill bottle cap, Pillsy, and its accompanying software application provides reminders to take a scheduled dosage of medication via bottle cap alerts and smartphone push notifications, text messages, and/or automated phone calls. The Pillsy application records dosing dispense date and time when the user opens the bottle. During the first 2 weeks of the trial, the electronic notifications will be disabled to determine a baseline measure of adherence. Within 1 day after Visit 2, the electronic notifications will be turned on for all participants, resulting in a series of alerts (via electronic pill bottle cap alerts and smartphone push notifications, text message, and/or automated phone calls).~The electronic pill bottle cap, Pillsy, is a commercially available device marketed to consumers. The electronic pill bottle cap does not capture or store PHI. Quick tips on how to use Pillsy can be found at https://www.pillsy.com/instructions"

Trial Locations (1)

27701

Duke Clinical Research Institute, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

Duke University

OTHER

NCT04358302 - Individual Patient Exposure and Response in Pediatric Lupus | Biotech Hunter | Biotech Hunter